175 related articles for article (PubMed ID: 15208912)
21. [Vitamin K antagonists].
D'Agostino F; D'Agostino M; Cambiè G; Cuccia A
Riv Emoter Immunoematol; 1983; 30(1):1-31. PubMed ID: 6635478
[No Abstract] [Full Text] [Related]
22. Risk factors of vitamin K antagonist overcoagulation. A case-control study in unselected patients referred to an emergency department.
Cadiou G; Varin R; Levesque H; Grassi V; Benichou J; Tiret I; Dieu B; Lecam-Duchez V; Borg JY; Muller JM; Benhamou Y; Marie I
Thromb Haemost; 2008 Oct; 100(4):685-92. PubMed ID: 18841293
[TBL] [Abstract][Full Text] [Related]
23. A rebuttal: vitamin K antagonists and cancer survival.
Zacharski LR; Henderson WG
Thromb Haemost; 2002 Jul; 88(1):173-4; author reply 175. PubMed ID: 12152670
[No Abstract] [Full Text] [Related]
24. [Anticoagulants in old age].
Sprung O
Phlebologie; 1973; 26(1):61-4. PubMed ID: 4724449
[No Abstract] [Full Text] [Related]
25. Thrombin generation test in patients under anticoagulant therapy with vitamin K antagonists.
Brocal I; Marco P; Lucas J; Verdú J; Tarín F
Thromb Haemost; 2009 Mar; 101(3):594-5. PubMed ID: 19277428
[No Abstract] [Full Text] [Related]
26. Anticoagulation control with vitamin K antagonists: how well are we doing?
Lane DA; Boos CJ; Lip GY
Chest; 2006 May; 129(5):1122-4. PubMed ID: 16684999
[No Abstract] [Full Text] [Related]
27. Optimal reversal of vitamin K antagonists.
Schulman S
Thromb Res; 2007; 119(1):15-6. PubMed ID: 16310838
[No Abstract] [Full Text] [Related]
28. [General practitioner's considerations if INR doesn't change].
Dick A; Spannagl M
MMW Fortschr Med; 2009 Jun; 151(26-29):32-3. PubMed ID: 19739544
[No Abstract] [Full Text] [Related]
29. [Vitamin K-controlled diet: problems and prospects].
Miggiano GA; Robilotta L
Clin Ter; 2005; 156(1-2):41-6. PubMed ID: 16080660
[TBL] [Abstract][Full Text] [Related]
30. Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention.
Garcia D; Ageno W; Bussey H; Eikelboom J; Margaglione M; Marongiu F; Moia M; Palareti G; Pengo V; Poli D; Schulman S; Witt D; Wittkowksy A; Crowther M
Am J Hematol; 2009 Sep; 84(9):579-83. PubMed ID: 19610022
[No Abstract] [Full Text] [Related]
31. [Electronarcosis while under anticoagulant treatment].
Loo H; Cuche H; Dusorbier X; Attali M
Ann Med Psychol (Paris); 1980 Feb; 138(2):234-40. PubMed ID: 7387052
[No Abstract] [Full Text] [Related]
32. The challenge of regulating anticoagulant drugs: focus on warfarin.
Mann KG
Am Heart J; 2005 Jan; 149(1 Suppl):S36-42. PubMed ID: 15644792
[No Abstract] [Full Text] [Related]
33. [Physiological and physiopathological bases for a rational anticoagulant therapy].
Raby C
J Sci Med Lille; 1968 Nov; 86(11):659-94. PubMed ID: 5701301
[No Abstract] [Full Text] [Related]
34. Recommendations on bleeding and nonbleeding complications of vitamin K antagonists.
Ansell J
Clin Adv Hematol Oncol; 2007 Jul; 5(7):517-8, 554. PubMed ID: 17679924
[No Abstract] [Full Text] [Related]
35. [The interaction between anticoagulant therapy with vitamin K-antagonists and treatment with antibiotics: a practical recommendation].
Zelis M; Zweegman S; van der Meer FJ; Kramer MH; Smulders YM
Ned Tijdschr Geneeskd; 2008 May; 152(18):1042-6. PubMed ID: 18547025
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves.
Yiu KH; Siu CW; Jim MH; Tse HF; Fan K; Chau MC; Chow WH
Am J Cardiol; 2006 Feb; 97(3):409-11. PubMed ID: 16442406
[TBL] [Abstract][Full Text] [Related]
37. [Therapeutic education of patients taking antivitamin K anticoagulants].
Chatelier R; Martinez R; Passeron M
Soins; 2003 May; Spec No 2():14-5. PubMed ID: 12820299
[No Abstract] [Full Text] [Related]
38. Challenges in managing anticoagulant therapy in patients with heart valve prostheses.
Vink R; Kamphuisen PW; van den Brink RB; Levi M
Expert Rev Cardiovasc Ther; 2007 May; 5(3):563-70. PubMed ID: 17489678
[TBL] [Abstract][Full Text] [Related]
39. Route of vitamin K administration for elevated INRs in the acute inpatient setting.
Mersfelder TL
Med Health R I; 2005 Dec; 88(12):441-2. PubMed ID: 16408720
[No Abstract] [Full Text] [Related]
40. [Vitamin K antagonists].
Lefrère JJ; Samama M
Soins; 1987 Dec; (507):45-9. PubMed ID: 3438754
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
